Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03829371
What this trial is testing

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Who this might be right for
Multiple Myeloma
University of Turin, Italy 450
Testing effectiveness (Phase 2)Study completedNCT02937571
What this trial is testing

High Dose Carfilzomib for Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Not applicableEnded earlyNCT03180853
What this trial is testing

Multiple Myeloma Patient Registry

Who this might be right for
Multiple Myeloma
Janssen Scientific Affairs, LLC 85
Large-scale testing (Phase 3)Study completedNCT01564537
What this trial is testing

Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Takeda 722
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Early research (Phase 1)Study completedNCT05270928
What this trial is testing

Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y001#

Who this might be right for
Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University 6
Testing effectiveness (Phase 2)Study completedNCT03398200
What this trial is testing

Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma

Who this might be right for
Myeloma
Omar Aljitawi 99
Early research (Phase 1)Ended earlyNCT04855136
What this trial is testing

Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 21
Testing effectiveness (Phase 2)WithdrawnNCT03221634
What this trial is testing

Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT02918695
What this trial is testing

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHematologic Diseases
Universitaire Ziekenhuizen KU Leuven 200
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Not applicableStudy completedNCT01362972
What this trial is testing

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor

Who this might be right for
LymphomaMultiple Myeloma
Genzyme, a Sanofi Company 7,801
Testing effectiveness (Phase 2)Ended earlyNCT01633281
What this trial is testing

Acupuncture for Peripheral Neuropathy

Who this might be right for
Peripheral Neuropathy Grade 2 or Greater
Singapore General Hospital 8
Not applicableLooking for participantsNCT07649681
What this trial is testing

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

Who this might be right for
Multiple Myeloma (MM)GI CancerTaste Disorder+2 more
Wuerzburg University Hospital 198
Not applicableUnknownNCT04746092
What this trial is testing

The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19

Who this might be right for
CLLMultiple MyelomaLymphoma
Tel-Aviv Sourasky Medical Center 630
Not applicableStudy completedNCT04248244
What this trial is testing

Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Case Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00193544
What this trial is testing

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 40
Early research (Phase 1)Looking for participantsNCT07341867
What this trial is testing

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

Who this might be right for
Multiple MyelomaTriple Negative Breast CancerDuffy Blood Group, Chemokine Receptor Gene Mutation+1 more
Andrew Hantel, MD 90
Testing effectiveness (Phase 2)UnknownNCT03975907
What this trial is testing

Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)

Who this might be right for
Multiple Myeloma
CARsgen Therapeutics Co., Ltd. 121
Testing effectiveness (Phase 2)WithdrawnNCT04584307
What this trial is testing

Phase II Study of Immunomaintenance Using POmalidomide With Elotuzumab afteR Second Autologous Transplant

Who this might be right for
Multiple Myeloma
Natalie Callendar
Next Page